NanoString’s Restructuring Culminates in Bruker Acquisition Deal

An update from NanoString Technologies (NSTGQ) is now available.

NanoString Technologies, Inc. underwent a significant shift in its restructuring journey after filing for Chapter 11 bankruptcy, culminating in an intense auction that ended with Bruker Corporation outbidding Patient Square Capital. The deal with Bruker, worth approximately $392.6 million in cash, also includes Bruker assuming certain liabilities, such as ongoing intellectual property litigation. This agreement supersedes an earlier one with Patient Square, which was terminated, albeit with a break-up fee and expense reimbursement owed to Patient Square. The successful auction and the new agreement with Bruker mark a pivotal point in NanoString’s efforts to navigate its financial challenges.

See more data about NSTGQ stock on TipRanks’ Stock Analysis page.